Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

Eisai launch bid for accelerated FDA approval for new Alzheimer’s drug

September 28, 2021 Manufacturing and Production, Medical Communications, Research and Development

Japanese drug maker Eisai has launched a bid for accelerated FDA approval for its new experimental drug for early Alzheimer’s …
News
sanofi_hq__boetie_hall_web

Sanofi drops mRNA COVID vaccine candidate amid success of rivals

September 28, 2021 Manufacturing and Production, Medical Communications

French healthcare group Sanofi has announced that it is dropping plans for its mRNA COVID vaccine due to the success …
News

FDA: Accelerated approval for Genmab and Seagen’s TIVDAK

September 21, 2021 Manufacturing and Production, Research and Development

The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate …
News
az

AstraZeneca to invest $340 million on Irish site

September 21, 2021 Manufacturing and Production

AstraZeneca has announced on Tuesday a $340 million plan to establish an active pharmaceutical ingredient (API) manufacturing facility for small …
News

Vectura removed from DDL Conference amid PMI deal

September 21, 2021 Manufacturing and Production DDL, inhalers, pmi, vectura

 Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to …
News

Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA

September 15, 2021 Manufacturing and Production, Medical Communications, Research and Development

On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …
News
nhs_sign

NHS in Scotland makes rheumatoid arthritis drug available

September 14, 2021 Manufacturing and Production Galapagos UK, NHS, Scotland, filgotinib, rheumatoid arthritis

The Scottish Medicines Consortium (SMC) have recommended the use of Galapagos UK’s JYSELECA® (filgotinib) for eligible patients with severe active …
News

Wider use of SGLT2 inhibitors for CVD recommended by NICE

September 7, 2021 Manufacturing and Production, Medical Communications

NICE has updated its guidelines on the management of type 2 diabetes, recommending wider use of SGLT2 inhibitors in those …
News

FDA halts BioMarin’s PKU gene therapy trial

September 7, 2021 Manufacturing and Production, Medical Communications, Research and Development

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …
News
nhs_sign

NHS to receive additional £5.4 billion for COVID-19 response

September 7, 2021 Manufacturing and Production

The NHS will receive an extra £5.4 billion over the next six months to support its response to COVID-19 and …
News

Vaginal ring could help prevent HIV infection in women

September 7, 2021 Manufacturing and Production, Research and Development

Researchers from the Kenya Medical Research Institute (KEMRI) are exploring the use of an intra vaginal ring containing anti-HIV medication …
News

“Highly effective” rheumatoid arthritis treatment possible after breakthrough

September 7, 2021 Manufacturing and Production

A “highly effective” treatment for rheumatoid arthritis could be made available in several years after scientists have uncovered a new …
News

Empagliflozin demonstrates significant improvement in heart failure outcomes

August 31, 2021 Manufacturing and Production

Empagliflozin (Jardiance) showed a significant 21% relative risk reduction for the composite primary endpoint of cardiovascular death or hospitalisation for …
News
sanofi_hq__boetie_hall_web

Dupilumab significantly reduces atopic dermatitis in children

August 31, 2021 Manufacturing and Production

A pivotal Phase III trial evaluating dupilumab for the treatment of children aged six months to five years with moderate-to-severe …
News
clinical_trials_2

Bone Therapeutics knee osteoarthritis Phase III study misses primary endpoints

August 31, 2021 Manufacturing and Production

Bone Therapeutics, the cell therapy company addressing unmet medical needs in orthopaedics and other diseases, announced that the Phase III …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026